Venlafaxine Hydrochloride
- Product NDC
- 69367-417
- 11-digit product format
- 693670417
- Labeler code
- 69367
- Product ID
- 69367-417_f5372620-d970-4c76-b148-35264d890c1a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Venlafaxine Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Westminster Pharmaceuticals, LLC
- Application
- ANDA205468
- Marketing category
- ANDA
- Marketing start
- 2025-11-18
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Venlafaxine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| VENLAFAXINE HYDROCHLORIDE | 150 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 7D7RX5A8MO |
| Rxcui | 808744, 808748 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69367-417-09 | Venlafaxine Hydrochloride | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | | 1 |
| 69367-417-30 | Venlafaxine Hydrochloride | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 69367-417-09 | 69367041709 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-417-09) | 2025-11-18 | No | No | Current |
| 69367-417-30 | 69367041730 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-417-30) | 2025-11-18 | No | No | Current |